Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK; CARMELINA Investigators.
Rosenstock J, et al. Among authors: meinicke t.
JAMA. 2019 Jan 1;321(1):69-79. doi: 10.1001/jama.2018.18269.
JAMA. 2019.
PMID: 30418475
Free PMC article.
Clinical Trial.